Rhodes John B

CIK 00013462511 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001346251

Recent Transactions

26 trades

Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2020-05-04+75,000→ 75,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-05-06+45,000→ 45,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-06-12+30,000→ 30,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2018-06-01$3.33/sh+7,500→ 23,470 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2017-06-20+30,000→ 30,000 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2017-05-27−1,125→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-05-27+1,125→ 15,970 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-02-09+1,125→ 14,845 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2017-02-09−1,125→ 0 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock Purchase Warrant
2016-10-31+25,000→ 25,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2016-10-31+25,000→ 137,196 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2016-06-21$2.00/sh+25,000→ 112,196 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2016-05-27+11,250→ 11,250 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2016-02-25−600→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2016-02-25+600→ 8,720 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2016-02-09+11,250
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2015-07-17$7.50/sh+6,000→ 81,196 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2015-02-25+7,500→ 7,500 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2015-02-25+6,000→ 6,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2014-10-29+7,500→ 7,500 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2014-02-11+5,500→ 5,500 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2013-08-14+11,765→ 75,196 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Series A common stock purchase warrant
2013-08-14+11,765→ 11,765 total
Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock
2013-04-26$0.40/sh+166,667→ 1,268,603 total
Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Warrants
2013-04-26−166,667→ 383,333 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2013-02-12+225,000→ 0 total

Companies

Tonix Pharmaceuticals Holding Corp.
Director
$TNXP

Recent Filings

Address

C/O TONIX PHARMACEUTICALS HOLDING CORP. 509 MADISON AVENUE, SUITE 306

NEW YORK, NY, 10022

View on SEC.gov